Figure 1
Figure 1. Genomic alterations in pBL. (A) Diagram of mutations identified by targeted genomic sequencing. Columns represent individual samples. Alterations listed include only those likely to be somatic as referenced in COSMIC,22 as well as MYC point mutations and indels of unknown significance. We detected copy number alterations by comparing targeted genomic DNA sequence coverage with a process-matched normal control sample. We detected genomic rearrangements by clustering chimeric reads mapping to targeted introns. (B) Distribution of frequency of alterations by EBV status. EBV-negative cases (EBV Neg) are significantly more likely to have > 1 alteration compared with EBV-positive cases (EBV Pos; P < .0001).

Genomic alterations in pBL. (A) Diagram of mutations identified by targeted genomic sequencing. Columns represent individual samples. Alterations listed include only those likely to be somatic as referenced in COSMIC,22  as well as MYC point mutations and indels of unknown significance. We detected copy number alterations by comparing targeted genomic DNA sequence coverage with a process-matched normal control sample. We detected genomic rearrangements by clustering chimeric reads mapping to targeted introns. (B) Distribution of frequency of alterations by EBV status. EBV-negative cases (EBV Neg) are significantly more likely to have > 1 alteration compared with EBV-positive cases (EBV Pos; P < .0001).

Close Modal

or Create an Account

Close Modal
Close Modal